Position in NTRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$424,004
+$105,820 QoQ
Shares Held
1,562
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#563
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $37,453,222 across 9 Diagnostics & Research names. NTRA ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
47,091 | $23,609,543 | |
| 2 | DHR |
Danaher Corp /De/
|
29,809 | $5,678,018 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
9,994 | $5,261,241 | |
| 4 | WAT |
Waters Corp /De/
|
2,003 | $751,205 | |
| 5 | LH |
Labcorp Holdings Inc.
|
2,241 | $627,480 | |
| 6 | ILMN |
Illumina, Inc.
|
3,006 | $528,544 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,562 | $424,004 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,638 | $350,405 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $424,004 | 1,562 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $318,184 | 1,591 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $359,213 | 1,568 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $212,963 | 1,323 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||